...
首页> 外文期刊>Journal of Cellular Physiology >RKIP: Much more than Raf Kinase inhibitory protein
【24h】

RKIP: Much more than Raf Kinase inhibitory protein

机译:RKIP:比Raf激酶抑制蛋白质

获取原文
获取原文并翻译 | 示例
           

摘要

From its discovery as a phosphatidylethanolamine-binding protein in bovine brain to its designation as a physiological inhibitor of Raf kinase protein, RKIP has emerged as a critical molecule for maintaining subdued, well-orchestrated cellular responses to stimuli. The disruption of RKIP in a wide range of pathologies, including cancer, Alzheimer's disease, and pancreatitis, makes it an exciting target for individualized therapy and disease-specific interventions. This review attempts to highlight recent advances in the RKIP field underscoring its potential role as a master modulator of many pivotal intracellular signaling cascades that control cellular growth, motility, apoptosis, genomic integrity, and therapeutic resistance. Specific biological and functional niches are highlighted to focus future research towards an enhanced understanding of the multiple roles of RKIP in health and disease.
机译:作为一个从其发现phosphatidylethanolamine-binding蛋白质牛脑称号生理Raf激酶蛋白的抑制剂,RKIP已成为一个关键分子保持低调,精心组织的细胞对刺激的反应。广泛的疾病,包括癌症、阿尔茨海默病,胰腺炎,使它一个令人兴奋的个性化治疗和目标针对疾病的干预措施。RKIP试图突出最新进展领域凸显出其潜在作用的主人许多重要的细胞内信号调制器级联控制细胞增长,能动性,细胞凋亡、基因完整性和治疗阻力。利基市场强调未来的研究重点向一个增强对多个的理解RKIP的角色在健康和疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号